Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
92%
Viral Load
44%
Human Immunodeficiency Virus 2
28%
Drug Resistance
25%
Viremia
25%
Blood Plasma
21%
Antibody Response
20%
Prevalence
16%
T-Helper Cell
16%
Integrase
15%
Cladistics
14%
Reverse Transcriptase
11%
Phylogeny
11%
CD4
10%
Next Generation Sequencing
9%
Kidney Transplantation
9%
Antibodies
9%
Dynamics
7%
T Cell Depletion
6%
Neutralizing Antibody
6%
Human Immunodeficiency Virus Type 1 Subtype B
6%
Cytotoxic T-Cell
5%
Viral Replication
5%
CD4 Lymphocyte Count
5%
Enzyme-Linked Immunosorbent Assay
5%
Codon
5%
Cell Activation
5%
Memory B Cell
5%
T Cell
5%
Peripheral Blood Mononuclear Cell
5%
Immunity
5%
Medicine and Dentistry
Human Immunodeficiency Virus
74%
Drug Resistance
45%
Resistance Mutation
18%
Integrase
14%
Nonnucleoside Reverse Transcriptase Inhibitor
14%
Antiretroviral Therapy
13%
Infection
12%
Reverse-Transcriptase Inhibitor
11%
Prevalence
11%
Kidney Graft
10%
Next Generation Sequencing
10%
Human Immunodeficiency Virus 1
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Antibody Response
9%
Human Immunodeficiency Virus 2
9%
Rilpivirine
9%
Viremia
6%
Proteinase Inhibitor
6%
Dolutegravir
5%
COVID-19
5%
Cohort Analysis
5%
Men Who Have Sex with Men
5%
Tenofovir
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
76%
Drug Resistance
26%
Human Immunodeficiency Virus
25%
Prevalence
11%
Protease Inhibitor
10%
Cladistics
8%
Reverse Transcriptase
8%
Integrase
7%
Virus Load
6%
Nucleoside
5%
Genetic Divergence
5%
CD4
5%
Genotyping
5%
